oral glp 1 tirzepatide FDA says shortage of GLP-1 drug is over Oral tirzepatide: what actually exists,

Peptides 24 , 569578 (2003)

Initial reports indicated improvement in psoriasis and hidradenitis suppurativaautoinflammatory dermatoses commonly associated with obesity and metabolic syndrome

In a study in which juvenile dogs received lisdexamfetamine dimesylate for 6 months beginning at 10 weeks of age, decreased bodyweight gain was seen at all doses tested (2, 5, and 12 mg/kg/day, which are approximately 0.5, 1, and 3 times the maximum recommended human daily dose on a mg/m2 basis for a child)

Opt for skincare products labeled as hypoallergenic and for sensitive skin. These products are formulated to be gentle and less likely to cause irritation